换一批Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms: A joint European LeukemiaNet/MPN&MPNr-EuroNet (COST action BM0902) study
第一作者：
Jovanovic,J.V.
作者：
Jovanovic,J.V. [1]
;
Ivey,A. [2]
;
Vannucchi,A.M. [3]
;
Lippert,E. [4]
;
OppligerLeibundgut,E. [5]
;
Cassinat,B. [6]
;
Pallisgaard,N. [7]
;
Maroc,N. [8]
;
Hermouet,S. [9]
;
Nickless,G. [10]
;
Guglielmelli,P. [11]
;
VanDerReijden,B.A. [12]
;
Jansen,J.H. [13]
;
Alpermann,T. [14]
;
Schnittger,S. [15]
;
Bench,A. [16]
;
Tobal,K. [17]
;
Wilkins,B. [18]
;
Cuthill,K. [19]
;
McLornan,D. [20]
;
Yeoman,K. [21]
;
Akiki,S. [22]
;
Bryon,J. [23]
;
Jeffries,S. [24]
;
Jones,A. [25]
;
Percy,M.J. [26]
;
Schwemmers,S. ;
Gruender,A. ;
Kelley,T.W. ;
Reading,S. ;
Pancrazzi,A. ;
McMullin,M.F. ;
Pahl,H.L. ;
Cross,N.C.P. ;
Harrison,C.N. ;
Prchal,J.T. ;
Chomienne,C. ;
Kiladjian,J.J. ;
Barbui,T. ;
Grimwade,D.
作者单位：
King's College London School of Medicine, Cancer Genetics Lab, Department of Medical and Molecular
[1]
Queen's University Belfast, Belfast, United Kingdom
[2]
Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
[3]
Department of Molecular Hematology, University Hospital Freiburg, Freiburg, Germany
[4]
Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Medical Centre
[5]
Department of Histopathology, Guys and St Thomas' NHS Foundation Trust, London, United Kingdom
[6]
Department of Pathology, University of Utah, Salt Lake City, UT, United States
[7]
MPD-Research Consortium, Hematology Division, University of Utah School of Medicine, Salt Lake City
[8]
Wessex Regional Genetics Laboratory, Salisbury, United Kingdom
[9]
Qiagen Marseille, Marseille, France
[10]
ARUP Laboratories, Salt Lake City, UT, United States
[11]
Ospedali Riuniti di Bergamo, Bergamo, Italy
[12]
Laboratoire d'Hématologie, Centre Hospitalier Universitaire, Bordeaux, France
[13]
West Midlands Regional Genetics Laboratory, Birmingham, United Kingdom
[14]
Inserm UMR-S940, Institut Universitaire d'Hématologie, Paris, France
[15]
King's College Hospital, Department of Haematology, London, United Kingdom
[16]
Department of Haematology, Belfast City Hospital, Belfast, United Kingdom
[17]
Centre Hospitalier Universitaire, Université de Nantes, Inserm U892, Nantes, France
[18]
Munich Leukemia Laboratory, Munich, Germany
[19]
Clinical Investigation Center (CIC), H?pital Saint-Louis, French Intergroup of Myeloproliferative
[20]
AP-HP, Unité de Biologie Cellulaire, H?pital Saint-Louis, Paris, France
[21]
Department of Haematology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom
[22]
Department of Hematology, University Hospital, University of Bern, Bern, Switzerland
[23]
Molecular Malignancy Laboratory, Haemato-Oncology Diagnostic Service, Addenbrooke's Hospital
[24]
Klinisk Biokemi, Vejle Sygehus, Vejle, Denmark
[25]
Molecular Oncology Diagnostics Unit, GSTS Pathology, London, United Kingdom
[26]
发布时间
2018-10-31
- 浏览2
Leukemia
Leukemia
2032-2039页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
